Benoı̂t Rousseau

6.7k citations

96 papers · 2.7k · 2 hit papers · h-index 25

Impact in

Hepatology top 2%
- Hepatocellular Carcinoma Treatment and Prognosis
Oncology top 2%
- Cancer Immunotherapy and Biomarkers
- Pancreatic and Hepatic Oncology Research
- Colorectal Cancer Treatments and Studies

Papers in

Oncology 50
- Colorectal Cancer Treatments and Studies 20
- Cancer Immunotherapy and Biomarkers 18
- Pancreatic and Hepatic Oncology Research 7
- Cancer Treatment and Pharmacology 6
- Colorectal Cancer Surgical Treatments 6
Pulmonary and Respiratory Medicine 25

Co-authors: Julien Caldéraro (7 shared papers)Alain Luciani (5 shared papers)Jean–Michel Pawlotsky (5 shared papers)Alexis Laurent (3 shared papers)Cécile Charpy (2 shared papers)Giuliana Amaddeo (2 shared papers)Fouad Lafdil (4 shared papers)Cindy Neuzillet (17 shared papers)
Journals: Journal of Clinical Oncology (9 papers)Annals of Oncology (8 papers)Clinical Cancer Research (3 papers)Hepatology (3 papers)European Journal of Cancer (3 papers)
Partner nations: France United States Spain

In The Last Decade

Benoı̂t Rousseau

89 papers receiving 2.7k citations

Hit Papers

align trajectories log scale

Intra-tumoral tertiary lymphoid structures are associated with a low risk of early recurrence of hepatocellular carcinoma 2018 · 315 citations

Peers

Countries citing papers authored by Benoı̂t Rousseau

Since Specialization

Citations

This map shows the geographic impact of Benoı̂t Rousseau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benoı̂t Rousseau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benoı̂t Rousseau more than expected).

Fields of papers citing papers by Benoı̂t Rousseau

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Benoı̂t Rousseau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benoı̂t Rousseau. The network helps show where Benoı̂t Rousseau may publish in the future.

Co-authors

The 25 scholars most cited alongside Benoı̂t Rousseau, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Benoı̂t Rousseau Line = papers co-authored together Benoı̂t Rousseau links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 96 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Programmed death ligand 1 expression in hepatocellular carcinoma: Relationship With clinical and pathological features Hepatology ·Julien Caldéraro, Benoı̂t Rousseau, Giuliana Amaddeo, Marion Mercey, Cécile Charpy, Charlotte Costentin, Alain Luciani, Elie‐Serge Zafrani, Alexis Laurent, Daniel Azoulay, Fouad Lafdil, Jean–Michel Pawlotsky Hit paper breakdown →	2016	351
2	Intra-tumoral tertiary lymphoid structures are associated with a low risk of early recurrence of hepatocellular carcinoma Journal of Hepatology ·Julien Caldéraro, Florent Petitprez, Étienne Becht, Alexis Laurent, Théo Z. Hirsch, Benoı̂t Rousseau, Alain Luciani, Giuliana Amaddeo, Jonathan Derman, Cécile Charpy, Jessica Zucman‐Rossi, Wolf H. Fridman, Catherine Sautès‐Fridman Hit paper breakdown →	2018	315
3	Circulating levels of interleukin-17 and cardiovascular outcomes in patients with acute myocardial infarction European Heart Journal ·Tabassome Simon, Soraya Taleb, Nicolas Danchin, Ludivine Laurans, Benoı̂t Rousseau, Simon Cattan, J M Montély, Olivier Dubourg, Alain Tedgui, Salma Kotti, Ziad Mallat	2012	145
4	PD-L1 expression in perihilar and intrahepatic cholangiocarcinoma Oncotarget ·Jacqueline Fontugne, Jérémy Augustin, Anaïs Pujals, Philippe Compagnon, Benoı̂t Rousseau, Alain Luciani, Christophe Tournigand, Daniel Cherqui, Daniel Azoulay, Jean–Michel Pawlotsky, Julien Caldéraro	2017	143
5	Angiogenesis and immune checkpoint inhibitors as therapies for hepatocellular carcinoma: current knowledge and future research directions Journal for ImmunoTherapy of Cancer ·Marc Hilmi, Cindy Neuzillet, Julien Caldéraro, Fouad Lafdil, Jean–Michel Pawlotsky, Benoı̂t Rousseau	2019	124
6	Structure and Inhibitory Effects on Angiogenesis and Tumor Development of a New Vascular Endothelial Growth Inhibitor Journal of Biological Chemistry ·Lior Zilberberg, Svitlana Shinkaruk, Olivier Lequin, Benoı̂t Rousseau, Martin Hagedorn, Francesco Costa, Dario Caronzolo, Maurice Balke, Xavier Canron, Odile Convert, Georges Laı̈n, Karine Gionnet, Mário A. Gonçalves, Mireille Bayle, Lorenzo Bello, Gérard Chassaing, Gérard Déléris, Andréas Bikfalvi	2003	103
7	Overexpression and role of the ATPase and putative DNA helicase RuvB-like 2 in human hepatocellular carcinoma Hepatology ·Benoı̂t Rousseau, Ludovic Ménard, Valérie Haurie, Danièle Taras, Jean‐Frédéric Blanc, François Moreau‐Gaudry, Philippe Metzler, Michel Hugues, Sandrine Boyault, Sylvie Lemière, Xavier Canron, Pierre Costet, Michael D. Cole, Charles Balabaud, Paulette Bioulac‐Sage, Jessica Zucman‐Rossi, Jean Rosenbaum	2007	90
8	Sorafenib exposure decreases over time in patients with hepatocellular carcinoma Investigational New Drugs ·Jennifer Arrondeau, Olivier Mir, Pascaline Boudou‐Rouquette, Romain Coriat, Stanislas Ropert, Guillaume Dumas, Manuel Rodrigues, Benoı̂t Rousseau, Benoı̂t Blanchet, François Goldwasser	2011	86
9	New insights into diagnosis and therapeutic options for proliferative hepatoblastoma Hepatology ·Katarzyna B. Hooks, Jérôme Audoux, Helena Fazli, Sarah Lesjean, Tony Ernault, Nathalie Dugot‐Senant, Thierry Lesté-Lasserre, Martin Hagedorn, Benoı̂t Rousseau, Coralie Danet, Sophie Branchereau, Laurence Brugières, Sophie Taque, Catherine Guettier, Monique Fabrè, Anne Rullier, Marie‐Annick Buendia, Thérèse Commes, Christophe F. Grosset, Anne‐Aurélie Raymond	2017	81
10	VEGF coordinates interaction of pericytes and endothelial cells during vasculogenesis and experimental angiogenesis Developmental Dynamics ·Martin Hagedorn, Maurice Balke, Annette M. Schmidt, Wilhelm Bloch, Haymo Kurz, Sophie Javerzat, Benoı̂t Rousseau, Jörg Wilting, Andréas Bikfalvi	2004	74
11	Immune Checkpoint Inhibition in Colorectal Cancer: Microsatellite Instability and Beyond Targeted Oncology ·Romain Cohen, Benoı̂t Rousseau, Joana Vidal, Raphaël Colle, Luis A. Diaz, Thierry André	2019	73
12	Metastatic colorectal cancer (mCRC): French intergroup clinical practice guidelines for diagnosis, treatments and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, SFR) Digestive and Liver Disease ·Jean–Marc Phelip, David Tougeron, David Léonard, Léonor Benhaïm, G. Désolneux, Aurélien Dupré, Pierre Michel, Christophe Penna, Christophe Tournigand, Christophe Louvet, Niki Christou, P. Chevallier, Anthony Dohan, Benoı̂t Rousseau, Olivier Bouché	2019	70
13	KRASoncogene in lung cancer: focus on molecularly driven clinical trials European Respiratory Review ·Emmanuelle Kempf, Benoı̂t Rousseau, Benjamin Besse, Luis Paz‐Ares	2016	68
14	Alternative Neisseria spp. type IV pilin glycosylation with a glyceramido acetamido trideoxyhexose residue Proceedings of the National Academy of Sciences ·Julia Chamot‐Rooke, Benoı̂t Rousseau, Fanny Lanternier, Guillain Mikaty, Émilie Mairey, Christian Malosse, Guy Bouchoux, Vladimir Pelicic, Luc Camoin, Xavier Nassif, Guillaume Duménil	2007	68
15	Polymerase proofreading domain mutations: New opportunities for immunotherapy in hypermutated colorectal cancer beyond MMR deficiency Critical Reviews in Oncology/Hematology ·R. Bourdais, Benoı̂t Rousseau, Anaïs Pujals, H. Boussion, Charlotte Joly, A Guillemin, Isabelle Baumgaertner, Cindy Neuzillet, Christophe Tournigand	2017	57
16	Immunogenicity and safety of the influenza A H1N1v 2009 vaccine in cancer patients treated with cytotoxic chemotherapy and/or targeted therapy: the VACANCE study Annals of Oncology ·Benoı̂t Rousseau, Pierre Loulergue, Olivier Mir, Anne Krivine, Salma Kotti, E Viel, Tabassome Simon, Aimery de Gramont, François Goldwasser, Odile Launay, C. Tournigand	2011	54
17	Preventing Pluripotent Cell Teratoma in Regenerative Medicine Applied to Hematology Disorders Stem Cells Translational Medicine ·Aurélie Bedel, François Béliveau, Isabelle Lamrissi‐Garcia, Benoı̂t Rousseau, Isabelle Moranvillier, Benoît Rucheton, Veronique Guyonnet‐Dupérat, Bruno Cardinaud, Hubert de Verneuil, François Moreau‐Gaudry, Sandrine Dabernat	2016	50
18	CD4 T Cell–Dependent Rejection of Beta-2 Microglobulin Null Mismatch Repair–Deficient Tumors Cancer Discovery ·Giovanni Germano, Steve Lu, Giuseppe Rospo, Simona Lamba, Benoı̂t Rousseau, Sonia Fanelli, Denise Stenech, Dung T. Le, John L. Hays, Maria Grazia Totaro, Vito Amodio, Rosaria Chilà, Anna Mondino, Luis A. Díaz, Federica Di Nicolantonio, Alberto Bardelli	2021	45
19	A Thurstonian model for the dual pair (4IAX) discrimination method Perception & Psychophysics ·Benoı̂t Rousseau, Daniel M. Ennis	2001	40
20	Impact of the per-operatory application of GLIADEL wafers (BCNU, carmustine) in combination with temozolomide and radiotherapy in patients with glioblastoma multiforme: Efficacy and toxicity Clinical Neurology and Neurosurgery ·P. Miglierini, Mohamed Bouchekoua, Benoı̂t Rousseau, Phong Dam Hieu, Jean-Pierre Malhaire, Olivier Pradier	2012	39

About Benoı̂t Rousseau

Benoı̂t Rousseau is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Pathology and Forensic Medicine and Cancer Research, having authored 96 papers that have together received 2.7k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (20 papers), Cancer Immunotherapy and Biomarkers (18 papers), Genetic factors in colorectal cancer (14 papers), Hepatocellular Carcinoma Treatment and Prognosis (10 papers), Pancreatic and Hepatic Oncology Research (7 papers), Cancer Genomics and Diagnostics (7 papers), Cancer Treatment and Pharmacology (6 papers) and Colorectal Cancer Surgical Treatments (6 papers). The work is most often cited by research in Hepatology (445 citations), Oncology (1.3k citations), Cancer Research (418 citations), Immunology (567 citations) and Pathology and Forensic Medicine (321 citations). Benoı̂t Rousseau has collaborated with scholars based in France, United States and Spain. Frequent co-authors include Julien Caldéraro, Alain Luciani, Jean–Michel Pawlotsky, Alexis Laurent, Cécile Charpy, Giuliana Amaddeo, Fouad Lafdil, Cindy Neuzillet, Christophe Tournigand and Daniel Azoulay. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Clinical Cancer Research, Hepatology and European Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Benoı̂t Rousseau

Impact in

Papers in i

In The Last Decade

Benoı̂t Rousseau

Hit Papers

Peers

Countries citing papers authored by Benoı̂t Rousseau

Fields of papers citing papers by Benoı̂t Rousseau

All Works

About Benoı̂t Rousseau

Explore authors with similar magnitude of impact

Papers in